Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review

International Journal of Nursing Studies

Volumn 59, Issue , 2016, Pages 177-196

  Ullman, Amanda J ^a,b   Cooke, Marie L ^a   Mitchell, Marion ^a,c   Lin, Frances ^a   New, Karen ^b,d   Long, Debbie A ^a,e   Mihala, Gabor ^a   Rickard, Claire M ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e LADY CILENTO CHILDREN S HOSPITAL   (Australia)

Author keywords

Catheter related infections; Central venous catheters; Evidence based practice; Occlusive dressings; Vascular access devices

Indexed keywords

BANDAGE; CENTRAL VENOUS CATHETERIZATION; DEVICES; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BANDAGES; CATHETERIZATION, CENTRAL VENOUS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84973100794     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2016.04.003     Document Type: Review

References (71)

1. Arvanati K., et al. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study. Crit. Care Med. 2012, 40(2):420-429.
2. Brandt B., et al. Comparison of central venous catheter dressings in bone marrow transplant recipients. Oncol. Nurs. Forum 1996, 23(5):829-836.
3. Broadhurst D. PICC catheter securement: a randomized controlled trial in the home care setting. J. Vasc. Access 2015, 15:218-219.
4. Calvino G.S., et al. Performance of new high performance dressings as compared to traditional ones in prevention infection and non-infection complications of catheters in ICU: a randomized controlled study. Intensive Care Med. 2014, S240.
5. Carrer S., et al. Effect of different sterile barrier precautions and central venous catheter dressing on the skin colonization around the insertion site. Min. Anaestesiol. 2005, 71(5):197-206.
6. Chambers S.T., et al. Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial. J. Hosp. Infect. 2005, 61(1):53-61.
7. Conly J.M., Grieves K., Peters B. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J. Infect. Dis. 1989, 159(2):310-319.
8. Crawford A.G., Fuhr J.P., Rao B. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections. Infect. Control Hosp. Epidemiol. 2004, 25(8):668-674.
9. Davidson L. Dressing subclavian catheters. Nurs. Times 1986, 82(7):40.
10. de Barros L.F., et al. Evaluation of two types of dressings used on central venous catheters for hemodialysis. Acta Paul. Enferm. 2009, 22:481-486.
11. Egger M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109):629-634.
12. Frasca D., Dahyot-Fizelier C., Mimoz O. Prevention of central venous catheter-related infection in the intensive care unit. Crit. Care 2010, 14(2):212.
13. Freiberger D., Bryant J., Marino B. The effects of different central venous line dressing changes on bacterial growth in a pediatric oncology population. J. Pediatr. Oncol. Nurs. 1992, 9(1):3-7.
14. Garland J., et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001, 1431-1436.
15. George J., Singh S., Deepshikha J. A prospective randomized comparative study between transparent and occlusive dressings for central venous catheters. Indian J. Hematol. Blood Transfus. 2011, 27(4):286.
16. Giles Y., Aksoy M., Tezelman S. What really affects the incidence of central venous catheter-related infections for short-term catheterization?. Acta Chir. Belg. 2002, 102(4):256-258.
17. Gu Y., et al. Transparent dressing versus iodine plus dressing and high-permeability dressing in pediatric central line maintenance: a randomize controlled study. Pediatr. Crit. Care Med. 2014, 15(4 Suppl.):40.
18. Hagerstrom M., Matthiesen K., Thuessen C.I. An improved dressing method for haemodialysis patients with permanent central venous catheters. Assoc. Inferm. Studio Lesioni Cutanee 1994.
19. Han Z., Liang S., Marschall J. Current strategies for the prevention and management of central line-associated bloodstream infections. Infect. Drug Resist. 2010, 10(3):147-163.
20. Higgins J.P., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
21. Higgins J.P.T., et al. Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions 2011, The Cochrane Collaboration, (Chapter 8). J.P.T. Higgins, S. Green (Eds.).
22. Hill M.L., et al. A silver-alginate-coated dressing to reduce peripherally inserted central catheter (PICC) infections in NICU patients: a pilot randomized controlled trial. J. Perinatol. 2010, 30(7):469-473.
23. Ho K., Litton E. Use of chlohexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J. Antimicrob. Chemother. 2006, 58:281-287.
24. Keenlyside D. Central venous catheters - a randomized comparative study of OpSite IV3000 and Tegaderm. Improving Catheter Site Care 1991, Royal Society of Medicine Services Limited. D.G. Maki (Ed.).
25. Keenlyside D. Avoiding an unnecessary outcome. A comparative trial between IV3000 and a conventional film dressing to assess rates of catheter-related sepsis. Prof. Nurse 1993, 8(5):288-291.
26. Khattak A.Z., et al. A randomized controlled evaluation of absorption of silver with the use of silver alginate (Algidex) patches in very low birth weight (VLBW) infants with central lines. J. Perinatol. 2010, 30(5):337-342.
27. Lawson M., et al. Comparison of transparent dressing to paper tape dressing over central venous catheter sites. NITA: Natl. Intraven. Therapy Assoc. 1986, 9(1):40-43.
28. Le Corre I., Delorme M., Cournoyer S. A prospective, randomized trial comparing a transparent dressing and a dry gauze on the exit site of long term central venous catheters of hemodialysis patients. J. Vasc. Access 2003, 4(2):56-61.
29. Lefebvre C., Manheimer E., Glanville F. Searching for studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 2011, The Cochrane Collaboration, (Chapter 6). J.P.T. Higgins, S. Green (Eds.).
30. Levy I., et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr. Infect. Dis. J. 2005, 4(8):676-679.
31. Liberati A., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009, 6. e100001000.
32. Little K., Palmer D. Central line exit sites: which dressing?. Nurs. Stand. 1998, 12(48):42-44.
33. Loveday H.P., et al. epic3:National evidence-based guidelines for preventing healthcare-associated infections. J. Hosp. Infect. 2014, 86(S1):S1-S70.
34. Lucas H., Attard-Montalto S. Central line dressings: study of infection rates. Paediatr. Nurs. 1996, 8(6):21-23.
35. Madeo M., et al. A randomized trial comparing Arglaes (a transparent dressing containing silver ions) to Tegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central vascular catheters. Intensive Crit. Care Nurs. 1998, 14(4):187-191.
36. Maki D., Wili L. Colonisation and infection associated with transparent dressings for central venous arterial and Hickman catheters: a comparative trial. Program and Abstracts of the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy 1984.
37. Maki D.G., et al. The efficacy of a chlorhexidine-impregnated sponge (biopatch) for the prevention of intravascular catheter-related infection - a prospective, randomized, controlled, multicenter study. Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy 2000.
38. Maki D.G., Kluger D.M., Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc. 2006, 81(9):1159-1171.
39. Mermel L.A., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 49:1-45.
40. Naimer S.A., Temira F. Evaluation of techniques for intravenous catheter and tubing fixation. Mil. Med. 2004, 169(1):79-81.
41. Neufeld M. A randomized control trial of the effectiveness of opsite wound versus IV3000 in maintaining an occlusive central line dressing, in Thesis for Master in Health Sciences 1991, The School of Graduate Studies, McMaster University.
42. Nikoletti S., et al. A prospective, randomized, controlled trial comparing transparent polyurethane and hydrocolloid dressings for central venous catheters. Am. J. Infect. Control 1999, 27(6):488-496.
43. O'Grady N.P., et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Morb. Mortal. Wkly. Rep. 2002, 51(RR-10):1-29.
44. O'Grady N.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Clin. Infect. Dis. 2011, 52(9):e162-e193.
45. Olson K., et al. Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites. J. Infus. Nurs. 2004, 27(1):37-44.
46. Olson C., Heilman J., Vascular Access Team of Abbott Northwestern Hospital Clinical performance of a new transparent chlorhexidine gluconate central venous catheter dressing. J. Assoc. Vasc. Access 2008, 13(1):13-16.
47. Pedrolo E., et al. Clinical controlled trial on central venous catheter dressings. Acta Paul. Enferm. 2011, 24(2):278-283.
48. Pedrolo E., Danski M.T., Vayego S.A. Chlorhexidine and gauze and tape dressings for central venous catheters: a randomized clinical trial. Rev. Lat. Am. Enferm. 2014, 22(5):764-771.
49. Petrosino B., Becker H., Christian B. Infection rates in central venous catheter dressings. Oncol. Nurs. Forum 1988, 15(6):709-717.
50. Powell C., et al. Evaluation of Opsite catheter dressings for parenteral nutrition: a prospective, randomized study. J. Parenter. Enter. Nutr. 1982, 6(1):43-46.
51. Powell C.R., et al. Op-site dressing study: a prospective randomised study evaluating povidone iodine ointment and extension set changes with 7-day Op-site dressings applied to total parenteral nutrition subclavian sites. J. Parenter. Enter. Nutr. 1985, 9(3):443-446.
52. Pronovost P., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 2006, 355(26):2725-2733.
53. Raad I., Hanna H., Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet 2007, 7:645-657.
54. Reeves B.C., et al. Including non-randomized studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane Collaboration, Available from www.cochrane-handbook.org (Chapter 13). J.P.T. Higgins, S. Green (Eds.).
55. Reynolds M.G., Tebbs S.E., Elliott T.S.J. Do dressings with increased permeability reduce the incidence of central venous catheter related sepsis?. Intensive Crit. Care Nurs. 1997, 13(1):26-29.
56. Roberts B., Cheung D. Biopatch - a new concept in antimicrobial dressings for invasive devices. Aust. Crit. Care 1998, 11(1):16-19.
57. Ruschulte H., et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann. Hematol. 2009, 88:267-272.
58. Safdar N., et al. Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis. Crit. Care Med. 2014, 42(7):1703-1712.
59. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann. Intern. Med. 2010, 152(11):726-732.
60. Schunemann H.J., Vist O.A., Higgins G.E., Deeks J.P.T., Glasziou J.J., et al. Interpreting results and drawing conclusions. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane and A.f.w.c.o. Collaboration, (Chapter 12). J.P.T. Higgins, S. Green (Eds.).
61. Schwebel C., et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the dressing study. Crit. Care Med. 2012, 40(1):11-17.
62. Shivnan J.C., et al. A comparison of transparent adherant and dry sterile gauze dressings for long-term central catheters in patients undergoing bone marrow transplant. Oncol. Nurs. Forum 1991, 18(8):1349-1356.
63. Scottish Intercollegiate Guidelines Network (SIGN) Search filters 2012, http://www.sign.ac.uk/methodology/filters.html#random.
64. Timsit J., et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter related sepsis in critically ill adults: a randomized controlled trial. J. Am. Med. Assoc. 2009, 301(12):1231-1241.
65. Timsit J.F., et al. Cost-benefit of a chlorhexidine impregnated sponges for prevention of catheter-related infections in adult ICU patients. 23rd ESICM Annual Congress 2010.
66. Timsit, et al. New materials and devices for preventing catheter-related infections. Ann. Intensive Care 2011, 1:34.
67. Timsit J.F., et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am. J. Respir. Crit. Care Med. 2012, 186(12):1272-1278.
68. Ullman A.J., et al. Dressings and securement devices for central venous catheters (CVC) (Protocol). Cochrane Database Syst. Rev. 2013, 2.
69. Webster J., et al. Gauze and tape and transparent polyurethane dressings for central venous catheters (review). Cochrane Database Syst. Rev. 2011, 11:1-35.
70. Wille J.C., Blusse van Oud Alblas A., Thewessen E.A.P.M. A comparison of two types of transparent film-type dressings in central venous therapy. J. Hosp. Infect. 1993, 23(2):113-121.
71. Yamamoto A., et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J. Vasc. Interv. Radiol. 2002, 13(1):77-81.